Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Osteoimmunology: interactions of the bone and immune system.

Lorenzo J, Horowitz M, Choi Y.

Endocr Rev. 2008 Jun;29(4):403-40. doi: 10.1210/er.2007-0038. Epub 2008 May 1. Review.

2.

Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-kappa B ligand.

Mochizuki A, Takami M, Kawawa T, Suzumoto R, Sasaki T, Shiba A, Tsukasaki H, Zhao B, Yasuhara R, Suzawa T, Miyamoto Y, Choi Y, Kamijo R.

J Immunol. 2006 Oct 1;177(7):4360-8.

3.

Cytokines regulating osteoclast formation and function.

Lee SK, Lorenzo J.

Curr Opin Rheumatol. 2006 Jul;18(4):411-8. Review.

PMID:
16763463
4.

Pathogen recognition and innate immunity.

Akira S, Uematsu S, Takeuchi O.

Cell. 2006 Feb 24;124(4):783-801. Review.

5.

IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways.

Zhao J, Kong HJ, Li H, Huang B, Yang M, Zhu C, Bogunovic M, Zheng F, Mayer L, Ozato K, Unkeless J, Xiong H.

J Biol Chem. 2006 Apr 14;281(15):10073-80. Epub 2006 Feb 16.

6.

RANKL-RANK signaling in osteoclastogenesis and bone disease.

Wada T, Nakashima T, Hiroshi N, Penninger JM.

Trends Mol Med. 2006 Jan;12(1):17-25. Epub 2005 Dec 13. Review.

PMID:
16356770
7.

How Toll-like receptors signal: what we know and what we don't know.

O'Neill LA.

Curr Opin Immunol. 2006 Feb;18(1):3-9. Epub 2005 Dec 15. Review.

PMID:
16343886
8.

Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis.

Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, Yeh WC, Lee SK, Lorenzo JA, Choi Y.

J Exp Med. 2005 Sep 5;202(5):589-95.

9.

NFAT and Osterix cooperatively regulate bone formation.

Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K, Takayanagi H.

Nat Med. 2005 Aug;11(8):880-5. Epub 2005 Jul 24.

PMID:
16041384
10.

Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.

Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW, Taniguchi T.

Nature. 2005 Mar 10;434(7030):243-9. Epub 2005 Jan 23.

PMID:
15665823
11.

Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells.

Tsujimura H, Tamura T, Kong HJ, Nishiyama A, Ishii KJ, Klinman DM, Ozato K.

J Immunol. 2004 Jun 1;172(11):6820-7.

12.

Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP.

Zhu C, Rao K, Xiong H, Gagnidze K, Li F, Horvath C, Plevy S.

J Biol Chem. 2003 Oct 10;278(41):39372-82. Epub 2003 Jul 22.

13.

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T.

Dev Cell. 2002 Dec;3(6):889-901.

14.

ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.

Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, Morse HC 3rd, Belardelli F, Gabriele L.

J Exp Med. 2002 Dec 2;196(11):1415-25.

15.

Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator.

Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T, Takeya T.

J Biol Chem. 2002 Oct 25;277(43):41147-56. Epub 2002 Aug 8.

16.

Stimulation by toll-like receptors inhibits osteoclast differentiation.

Takami M, Kim N, Rho J, Choi Y.

J Immunol. 2002 Aug 1;169(3):1516-23.

17.

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.

Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T.

Nature. 2002 Apr 18;416(6882):744-9.

PMID:
11961557
18.

ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.

Tamura T, Ozato K.

J Interferon Cytokine Res. 2002 Jan;22(1):145-52. Review.

PMID:
11846985
19.

A novel member of the leukocyte receptor complex regulates osteoclast differentiation.

Kim N, Takami M, Rho J, Josien R, Choi Y.

J Exp Med. 2002 Jan 21;195(2):201-9.

20.

PU.1/Interferon Regulatory Factor interactions: mechanisms of transcriptional regulation.

Marecki S, Fenton MJ.

Cell Biochem Biophys. 2000;33(2):127-48. Review.

PMID:
11325034

Supplemental Content

Support Center